Skip to main content
TrimSoMoEverything GLP-1, in one place
Medication Reference

FDA-approved GLP-1 medications for weight loss

Familiar brands. Linked to official sources.

Choose a medication to read its FDA-approved uses, dose schedule, and safety information, with links to the official prescribing information.

Interactive Filter

Filter FDA-Approved GLP-1 Medications

Switch between weekly injections and daily oral options, or view the side-by-side comparison table.

Side-by-Side Comparison →
Filter by:
Weekly InjectionFDA-approved

Wegovy

semaglutide

Dosing:Once weekly, subcutaneous
Form: Injection: prefilled, single-dose pen
Weekly InjectionFDA-approved

Zepbound

tirzepatide

Dosing:Once weekly, subcutaneous
Form: Injection: single-dose pen or single-dose vial; multi-dose vial or single-patient-use KwikPen
Daily Oral TabletFDA-approved

Wegovy Tablets

oral semaglutide

Dosing:Once daily (morning, empty stomach)
Form: Oral: 1.5 mg, 4 mg, 9 mg, and 25 mg tablets
Daily Oral TabletFDA-approved

Foundayo

orforglipron

Dosing:Once daily (with or without food)
Form: Oral: film-coated tablets (0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg)

Detailed Medication Profiles & Dosage Guidelines

Review manufacturer information, starting doses, and titration schedules from official labeling.

Abstract illustration of a soft molecule shape above a weekly calendar grid

Wegovy

semaglutide · once weekly, subcutaneous

FDA-approved to reduce excess body weight and maintain weight reduction long term · see label

FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.

Abstract illustration of two intertwined molecule shapes beside a weekly desk calendar

Zepbound

tirzepatide · once weekly, subcutaneous

FDA-approved to reduce excess body weight and maintain weight reduction long term · see label

FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.

Illustration of a single round tablet on a clay saucer beside an opaque cup and a blank calendar card

Wegovy Tablets

oral semaglutide · once daily (morning, empty stomach)

FDA-approved to reduce excess body weight and maintain weight reduction long term · see label

FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.

Illustration of a single round tablet on a circular clay plinth beside a terracotta meal bowl

Foundayo

orforglipron · once daily (with or without food)

FDA-approved to reduce excess body weight and maintain weight reduction long term · see label

FDA-approved uses, dose schedule, and safety information, with a link to the official prescribing information.

Interactive Decision Tool

GLP-1 Insurance & Savings Card Cost Estimator

Estimate your realistic out-of-pocket monthly expense and determine manufacturer copay card eligibility rules.

Prior Authorization Guide →

Selected: Zepbound (Tirzepatide weekly injection). List price before insurance or coupons: ~$1,060 / 28-day supply.

Estimated Monthly Out-of-Pocket
$25 – $150 / month
Fully Eligible for Savings Card

Your commercial insurance plan covers anti-obesity medications on its formulary.

  • Manufacturer copay cards from Eli Lilly typically reduce out-of-pocket costs to as low as $25/month for up to 12 or 24 months.
  • Maximum manufacturer benefit caps generally range from $150 to $225 per month ($1,800 to $2,100 per calendar year).
  • Subject to pharmacy benefit manager (PBM) tier placement and your plan deductible requirements.
Prescriber Action Plan: Ask your prescribing doctor to submit a comprehensive Prior Authorization (PA) packet confirming BMI qualification and comorbidity documentation to satisfy plan coverage rules.

PA requirement notes: Approval typically requires documented BMI ≥30 or BMI ≥27 with at least one metabolic comorbidity, plus notes on prior lifestyle intervention attempts.

Need a prescriber to file a Prior Authorization?

Transparency & Compliance Notice: Out-of-pocket estimates are educational benchmarks reflecting published manufacturer coupon guidelines, wholesale acquisition cost benchmarks, and commercial health plan rules as of 2026. TrimSoMo is an independent, non-commercial informational directory and has no financial affiliation with Novo Nordisk, Eli Lilly, or pharmacy benefit managers (PBMs). Final copays are determined solely by your employer contract, insurer deductible, and dispensing pharmacy.

Unsure Which Fits Your Situation?

Talk with a licensed clinician

You do not need to pick a brand here. A licensed clinician decides whether a medication is appropriate for you. Confirm costs and coverage directly with providers, pharmacies, or your insurer.